Administering Haldol IV requires meticulous precision. Always use a diluted solution, typically 5 mg/mL, and inject slowly, at a rate no faster than 1-2 mg per minute. Careful monitoring of the patient’s vital signs is crucial throughout the process.
Before initiating the infusion, verify the patient’s identity and confirm the correct dose using two separate identifiers. Prepare the injection site with appropriate antiseptic, and ensure the IV line is patent and functioning correctly. Closely observe the patient for any adverse reactions, such as hypotension or extrapyramidal symptoms, during and after administration.
Should extrapyramidal symptoms (EPS) appear, immediately reduce the infusion rate or temporarily halt the administration. Have anticholinergic medications readily available to manage these reactions. Always consult your institution’s approved protocols and guidelines. Proper documentation, including the time of administration, dose, route, and any observed reactions, is paramount for maintaining patient safety and a clear medical record. Document everything accurately and thoroughly.
Remember, patient monitoring continues after the Haldol IV is complete. Closely watch for any delayed reactions. Post-administration observation time will vary depending on individual patient factors and the institution’s protocols. The primary goal is to ensure the safe and effective delivery of the medication, mitigating risks and ensuring patient well-being.
